Fingerprint
Dive into the research topics of 'Risk of Systemic Adverse Events after Intravitreal Bevacizumab, Ranibizumab, and Aflibercept in Routine Clinical Practice'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Risk of Systemic Adverse Events after Intravitreal Bevacizumab, Ranibizumab, and Aflibercept in Routine Clinical Practice
Maya H. Maloney, Stephanie R. Payne, Jeph Herrin, Lindsey R. Sangaralingham, Nilay D. Shah, Andrew J. Barkmeier
Research output: Contribution to journal › Article › peer-review
4
Scopus
citations